It is evident that the successful B3GNT5 deletion performed in this study may be further applied to investigate the lectin binding specificities (e.g. Shiga toxin) in other human cancer cell lines expressing Gb3, nLc4 and P1. The gene discussed is B3GNT5; the disease is cancer.